Insilico Medicine competitors

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Kurt Graves is the Chairman, President and Chief Executive Officer of Intarcia. Prior to joining Intarcia, Mr. Graves was EVP, Chief Commercial Officer and Head of Corporate and Strategic Development at Vertex Pharmaceuticals. Prior to his tenure at Vertex, he spent nearly 10 years at Novartis Pharmaceuticals, most recently as Global Head of the General Medicines Business & Chief Marketing Officer for the Pharmaceuticals division. Mr. Graves also previously held several commercial and general management positions at Merck and Astra Merck/Astra Pharmaceuticals, where he spent most of his time leading the GI Business Unit responsible for Prilosec and Nexium. Mr. Graves earned his B.S. in biology from Hillsdale College and has attended executive leadership programs at Harvard University, the University of Pennsylvania Wharton School of Management and University of Michigan.

CEO @ ProofPilot. Personal and professional goal to find real answers about personal and societal health & performance by democratizing research process.

Emily Leproust is an American scientist and entrepreneur. She is the CEO and co-founder of Twist Bioscience, a public company working on DNA synthesis. The company harnesses synthetic biology, providing tools to manufacture insulin from yeast, to tackle malaria, produce spider silk at scale or store information on DNA. She was awarded the BIO Rosalind Franklin Award in 2020.

Tom Langan is a senior executive with extensive life sciences, payer and data & analytics experience. He has more 25 years of broad-based functional experience in sales, marketing, strategy and P&L management. Tom leads the Veradigm business unit within Allscripts. Veradigm is the new brand for our Payer & Life Sciences business unit. Veradigm includes our life sciences data & analytics and clinical research businesses, health plan, clinical workflow solutions and Practice Fusion, one of the most widely used cloud-based EHRs for independent physicians. Previously, Tom has held executive positions at Symphony Health Solutions and MediMedia where he managed their life sciences data, analytics and consulting business, market access and multi-channel marketing solutions. During his career, Tom has served as President, Chief Commercial Officer, SVP of Sales and various business development roles working with payers, employers and life sciences organizations. Tom received a B.A. in Political Science from Fordham University in New York. He resides in Monmouth County, NJ, with his wife and children.